Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 106 AL 120

PUBMED

Memory deficits in the transgenic rat model of Huntington's disease.

Zeef DH, van Goethem NP, Vlamings R, Schaper F, Jahanshahi A, Hescham S, von Hörsten S, Prickaerts J, Temel Y.

Behav Brain Res. 2012 Feb 1;227(1):194-8. doi: 10.1016/j.bbr.2011.11.009.

0

0

0

PUBMED

Deep brain stimulation in Huntington's disease: A 4-year follow-up case report.

Spielberger S, Hotter A, Wolf E, Eisner W, Müller J, Poewe W, Seppi K.

Mov Disord. 2012 May;27(6):806-7; author reply 807-8. doi: 10.1002/mds.24959. No abstract available.

0

0

0

PUBMED

Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.

Looi JC, Rajagopalan P, Walterfang M, Madsen SK, Thompson PM, Macfarlane MD, Ching C, Chua P, Velakoulis D.

Aust N Z J Psychiatry. 2012 Dec;46(12):1145-58. doi: 10.1177/0004867412457224.

0

0

0

PUBMED

Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.

Kovalenko M, Dragileva E, St Claire J, Gillis T, Guide JR, New J, Dong H, Kucherlapati R, Kucherlapati MH, Ehrlich ME, Lee JM, Wheeler VC.

PLoS One. 2012;7(9):e44273. doi: 10.1371/journal.pone.0044273.

0

0

0

PUBMED

Chorea-acanthocytosis.

Sokolov E, Schneider SA, Bain PG.

Pract Neurol. 2012 Feb;12(1):40-3. doi: 10.1136/practneurol-2011-000045. No abstract available.

0

0

0

PUBMED

α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.

Tomás-Zapico C, Díez-Zaera M, Ferrer I, Gómez-Ramos P, Morán MA, Miras-Portugal MT, Díaz-Hernández M, Lucas JJ.

Hum Mol Genet. 2012 Feb 1;21(3):495-510. doi: 10.1093/hmg/ddr507.

0

0

0

PUBMED

Mutation in the CHAC gene in a family of autosomal dominant chorea-acanthocytosis.

Walker RH, Velayos-Baeza A, Bader B, Danek A, Saiki S.

Neurology. 2012 Jul 10;79(2):198-9; author reply 199. doi: 10.1212/01.wnl.0000416389.94466.01. No abstract available.

0

0

0

PUBMED

Pharmacologic approaches to the treatment of Huntington's disease.

Venuto CS, McGarry A, Ma Q, Kieburtz K.

Mov Disord. 2012 Jan;27(1):31-41. doi: 10.1002/mds.23953. Review.

0

0

0

PUBMED

Scanning Patterns of Faces do not Explain Impaired Emotion Recognition in Huntington Disease: Evidence for a High Level Mechanism.

van Asselen M, Júlio F, Januário C, Campos EB, Almeida I, Cavaco S, Castelo-Branco M.

Front Psychol. 2012 Feb 16;3:31. doi: 10.3389/fpsyg.2012.00031.

0

0

0

PUBMED

8OHdG as a marker for Huntington disease progression.

Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

Neurobiol Dis. 2012 Jun;46(3):625-34. doi: 10.1016/j.nbd.2012.02.012.

0

0

0

PUBMED

Network methods for describing sample relationships in genomic datasets: application to Huntington's disease.

Oldham MC, Langfelder P, Horvath S.

BMC Syst Biol. 2012 Jun 12;6:63. doi: 10.1186/1752-0509-6-63.

0

0

0

PUBMED

Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.

Chang KH, Chen YC, Wu YR, Lee WF, Chen CM.

PLoS One. 2012;7(9):e46492. doi: 10.1371/journal.pone.0046492.

0

0

0

PUBMED

Intergenerational instability in Huntington disease: extreme repeat changes among 134 transmissions.

Ramos EM, Cerqueira J, Lemos C, Pinto-Basto J, Alonso I, Sequeiros J.

Mov Disord. 2012 Apr;27(4):583-5. doi: 10.1002/mds.24065. No abstract available.

0

0

0

PUBMED

Mutant huntingtin impairs immune cell migration in Huntington disease.

Kwan W, Träger U, Davalos D, Chou A, Bouchard J, Andre R, Miller A, Weiss A, Giorgini F, Cheah C, Möller T, Stella N, Akassoglou K, Tabrizi SJ, Muchowski PJ.

J Clin Invest. 2012 Dec;122(12):4737-47. doi: 10.1172/JCI64484.

0

0

0

PUBMED

Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Martin B, Chadwick W, Cong WN, Pantaleo N, Daimon CM, Golden EJ, Becker KG, Wood WH 3rd, Carlson OD, Egan JM, Maudsley S.

J Biol Chem. 2012 Sep 14;287(38):31766-82. doi: 10.1074/jbc.M112.387316.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy